Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Invivyd, Inc. | Chief Executive Officer, Director | Stock Option (Right to Buy) | 950K | Dec 18, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
IVVD | Invivyd, Inc. | Dec 18, 2023 | 1 | $0 | 4 | Dec 20, 2023 | Chief Executive Officer, Director |
IVVD | Invivyd, Inc. | Dec 14, 2022 | 2 | $0 | 4 | Dec 16, 2022 | Chief Executive Officer, Director |
IVVD | Adagio Therapeutics, Inc. | Sep 1, 2022 | 1 | $36.2K | 4 | Sep 1, 2022 | Chief Executive Officer, Director |
IVVD | Adagio Therapeutics, Inc. | Jul 5, 2022 | 1 | $0 | 4 | Jul 6, 2022 | Chief Executive Officer, Director |
IVVD | Adagio Therapeutics, Inc. | Jan 30, 2022 | 1 | $0 | 4 | Feb 1, 2022 | Chief Operating Officer |
IVVD | Adagio Therapeutics, Inc. | Aug 5, 2021 | 0 | $0 | 3 | Aug 5, 2021 | Chief Operating Officer |